DELRAY BEACH, Fla., Jan. 15, 2026 /PRNewswire/ -- According to MarketsandMarkets, the Drug Discovery Technologies Market is projected to grow from about USD 30.58 billion in 2025 to USD 51.51 billion by 2030, at a CAGR of 11.0%.
Browse 400 market data tables and 50 figures spread through 450 pages and an in-depth TOC on "Drug Discovery Technologies Market - Global Forecast to 2030"
Drug Discovery Technologies Market Size & Forecast:
- Market Size Available for Years: 2024-2030
- 2025 Market Size: USD 30.58 billion
- 2030 Projected Market Size: USD 51.51 billion
- CAGR (2025-2030): 11.0%
Drug Discovery Technologies Market Trends & Insights:
- the reagents & consumables segment accounted for the largest share of the drug discovery technologies market in 2024.
- the high-throughput screening technologies segment accounted for the largest share of the drug discovery technologies market in 2024.
- the oncology segment accounted for the largest share of the drug discovery technologies market in 2024.
- North America accounted for the largest share of the drug discovery technologies market in 2024.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=35597436
The drug discovery technologies market is expanding as companies, biotech firms, and academic research centers adopt tools to accelerate early-stage research. Key technologies include high-throughput screening, genomics, proteomics, and bioanalytical platforms that aid in compound identification and target validation. Progress in automation, AI-driven data analysis, and integrated workflows improves reproducibility and enables more informed decision-making. Companies are investing in cell-based assays, on-chip systems, and imaging technologies to reliably predict drug efficacy and safety. Together, these advancements support faster, more reliable development of new therapeutics.
By technology, the high-throughput screening segment held the largest share of the drug discovery technologies market in 2024.
the drug discovery technologies market is segmented into high-throughput screening technologies, next-generation sequencing, polymerase chain reaction, in-silico/AI-based drug discovery technologies, X-ray crystallography, chromatography, mass spectrometry, and other technologies. In 2024, high-throughput screening accounted for the largest market share. This is because high-throughput screening facilitates the rapid screening of a huge number of compounds within a short period of time against biological targets. The technology has immense applications in the drug discovery stages of organizations associated with the pharmaceutical and biotechnology industries.
Request Sample Pages@https://www.marketsandmarkets.com/requestsampleNew.asp?id=35597436
By therapeutic area, the oncology segment accounted for the largest share of the drug discovery technologies market in 2024.
the drug discovery technologies market is segmented into oncology, infectious diseases, cardiovascular diseases, neurological diseases, endocrine & metabolic diseases, autoimmune disorders, and other therapeutic areas. In 2024, oncology held the largest share in the drug discovery technologies market. This is attributed to the number of cancer research initiatives and an increased emphasis on targeted and personalized treatment approaches. Pharmaceutical companies utilize modern discovery tools to identify new drug targets, test large numbers of compounds, and select more effective lead candidates. The growing number of cancer cases, strong clinical pipelines, and steady funding from public and private sources continue to support the leading position of the oncology segment.
North America accounted for the largest share of the market in 2024.
In 2024, North America held the largest share of the drug discovery technologies market. This is backed by a pharmaceutical and biotech foundation, along with the swift uptake of cutting-edge discovery tools. The US stands at the forefront in research funding, technological advancements, and regulatory encouragement for drug creation. The strong presence of contract research organizations, research institutes, and large pharmaceutical companies increases demand for screening, data analysis, and modeling tools. Ongoing clinical programs, steady funding, and close industry-research collaboration further support market growth in North America.
Inquire Before Buying@https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=35597436
Top Companies in Drug Discovery Technologies Market:
The Top Companies in Drug Discovery Technologies Market include Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Agilent Technologies, Inc. (US), Illumina, Inc. (US), Revvity, (US), F. Hoffmann-La Roche Ltd (Switzerland), Bruker (US), QIAGEN (Germany), and Bio-Rad Laboratories, Inc. (US), among others.
Browse Adjacent Markets: Biotechnology Market Research Reports & Consulting
Related Reports:
High Throughput Screening Market - Global Forecast to 2029
Next Generation Sequencing Market - Global Forecast to 2029
PCR Technologies Market - Global Forecast to 2030
Drug Discovery Services Market - Global Forecast to 2030
Artificial Intelligence in Drug Discovery Market - Global Forecast to 2029
About MarketsandMarkets
MarketsandMarkets has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/drug-discovery-technologies-market-worth-51-51-billion-by-2031--marketsandmarkets-302662241.html
